Report Detail

Request for Sample of this report

Pharma & Healthcare Global Diagnostic Nuclear Medicines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

  • RnM4607333
    • |
  • 13 August, 2024
    • |
  • Global
    • |
  • 113 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Diagnostic Nuclear Medicines market size was valued at USD 4858.7 million in 2023 and is forecast to a readjusted size of USD 7601.8 million by 2030 with a CAGR of 6.6% during review period.
Diagnostic radiopharmaceuticals. Radiopharmaceuticals are radioisotopes bound to biological molecules able to target specific organs, tissues or cells within the human body. These radioactive drugs can be used for the diagnosis
The diagnostic radioisotopes market is driven by the increasing prevalence of cancer and cardiovascular diseases, which require advanced imaging techniques for accurate diagnosis and treatment planning. Diagnostic radioisotopes are radioactive compounds used in nuclear medicine imaging to visualize and evaluate physiological processes and detect specific diseases in the body. The rise in the aging population and the need for early and precise diagnosis contribute to market growth. Moreover, advancements in radiopharmaceutical research and the development of new radioisotopes have improved the sensitivity and specificity of diagnostic imaging. However, the market also faces challenges, including the high cost of production and limited availability of some radioisotopes. Additionally, ensuring regulatory compliance and addressing concerns regarding radiation safety can pose obstacles for manufacturers and healthcare facilities. To succeed, companies must focus on research and development to offer innovative and diverse diagnostic radioisotopes, collaborate with healthcare providers to improve nuclear medicine imaging capabilities, and address the challenges to meet the increasing demand for effective and safe diagnostic imaging solutions.
The Global Info Research report includes an overview of the development of the Diagnostic Nuclear Medicines industry chain, the market status of Oncology (Tc-99m, F-18), Cardiology (Tc-99m, F-18), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Diagnostic Nuclear Medicines.
Regionally, the report analyzes the Diagnostic Nuclear Medicines markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Diagnostic Nuclear Medicines market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Diagnostic Nuclear Medicines market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Diagnostic Nuclear Medicines industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Tc-99m, F-18).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Diagnostic Nuclear Medicines market.
Regional Analysis: The report involves examining the Diagnostic Nuclear Medicines market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Diagnostic Nuclear Medicines market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Diagnostic Nuclear Medicines:
Company Analysis: Report covers individual Diagnostic Nuclear Medicines manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Diagnostic Nuclear Medicines This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Cardiology).
Technology Analysis: Report covers specific technologies relevant to Diagnostic Nuclear Medicines. It assesses the current state, advancements, and potential future developments in Diagnostic Nuclear Medicines areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Diagnostic Nuclear Medicines market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Diagnostic Nuclear Medicines market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Tc-99m
F-18
Other
Market segment by Application
Oncology
Cardiology
Other
Major players covered
Cardinal Health
GE Healthcare
Curium Pharma
Jubilant Pharma
Bracco Imaging
Novartis
SIEMENS
China Isotope & Radiation
Dongcheng
Lantheus
Eli Lilly
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Diagnostic Nuclear Medicines product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Diagnostic Nuclear Medicines, with price, sales, revenue and global market share of Diagnostic Nuclear Medicines from 2019 to 2024.
Chapter 3, the Diagnostic Nuclear Medicines competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Diagnostic Nuclear Medicines breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Diagnostic Nuclear Medicines market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Diagnostic Nuclear Medicines.
Chapter 14 and 15, to describe Diagnostic Nuclear Medicines sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Diagnostic Nuclear Medicines
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Diagnostic Nuclear Medicines Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Tc-99m
    • 1.3.3 F-18
    • 1.3.4 Other
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Diagnostic Nuclear Medicines Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Oncology
    • 1.4.3 Cardiology
    • 1.4.4 Other
  • 1.5 Global Diagnostic Nuclear Medicines Market Size & Forecast
    • 1.5.1 Global Diagnostic Nuclear Medicines Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Diagnostic Nuclear Medicines Sales Quantity (2019-2030)
    • 1.5.3 Global Diagnostic Nuclear Medicines Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Cardinal Health
    • 2.1.1 Cardinal Health Details
    • 2.1.2 Cardinal Health Major Business
    • 2.1.3 Cardinal Health Diagnostic Nuclear Medicines Product and Services
    • 2.1.4 Cardinal Health Diagnostic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Cardinal Health Recent Developments/Updates
  • 2.2 GE Healthcare
    • 2.2.1 GE Healthcare Details
    • 2.2.2 GE Healthcare Major Business
    • 2.2.3 GE Healthcare Diagnostic Nuclear Medicines Product and Services
    • 2.2.4 GE Healthcare Diagnostic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 GE Healthcare Recent Developments/Updates
  • 2.3 Curium Pharma
    • 2.3.1 Curium Pharma Details
    • 2.3.2 Curium Pharma Major Business
    • 2.3.3 Curium Pharma Diagnostic Nuclear Medicines Product and Services
    • 2.3.4 Curium Pharma Diagnostic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Curium Pharma Recent Developments/Updates
  • 2.4 Jubilant Pharma
    • 2.4.1 Jubilant Pharma Details
    • 2.4.2 Jubilant Pharma Major Business
    • 2.4.3 Jubilant Pharma Diagnostic Nuclear Medicines Product and Services
    • 2.4.4 Jubilant Pharma Diagnostic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Jubilant Pharma Recent Developments/Updates
  • 2.5 Bracco Imaging
    • 2.5.1 Bracco Imaging Details
    • 2.5.2 Bracco Imaging Major Business
    • 2.5.3 Bracco Imaging Diagnostic Nuclear Medicines Product and Services
    • 2.5.4 Bracco Imaging Diagnostic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Bracco Imaging Recent Developments/Updates
  • 2.6 Novartis
    • 2.6.1 Novartis Details
    • 2.6.2 Novartis Major Business
    • 2.6.3 Novartis Diagnostic Nuclear Medicines Product and Services
    • 2.6.4 Novartis Diagnostic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Novartis Recent Developments/Updates
  • 2.7 SIEMENS
    • 2.7.1 SIEMENS Details
    • 2.7.2 SIEMENS Major Business
    • 2.7.3 SIEMENS Diagnostic Nuclear Medicines Product and Services
    • 2.7.4 SIEMENS Diagnostic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 SIEMENS Recent Developments/Updates
  • 2.8 China Isotope & Radiation
    • 2.8.1 China Isotope & Radiation Details
    • 2.8.2 China Isotope & Radiation Major Business
    • 2.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Product and Services
    • 2.8.4 China Isotope & Radiation Diagnostic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 China Isotope & Radiation Recent Developments/Updates
  • 2.9 Dongcheng
    • 2.9.1 Dongcheng Details
    • 2.9.2 Dongcheng Major Business
    • 2.9.3 Dongcheng Diagnostic Nuclear Medicines Product and Services
    • 2.9.4 Dongcheng Diagnostic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Dongcheng Recent Developments/Updates
  • 2.10 Lantheus
    • 2.10.1 Lantheus Details
    • 2.10.2 Lantheus Major Business
    • 2.10.3 Lantheus Diagnostic Nuclear Medicines Product and Services
    • 2.10.4 Lantheus Diagnostic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Lantheus Recent Developments/Updates
  • 2.11 Eli Lilly
    • 2.11.1 Eli Lilly Details
    • 2.11.2 Eli Lilly Major Business
    • 2.11.3 Eli Lilly Diagnostic Nuclear Medicines Product and Services
    • 2.11.4 Eli Lilly Diagnostic Nuclear Medicines Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Eli Lilly Recent Developments/Updates

3 Competitive Environment: Diagnostic Nuclear Medicines by Manufacturer

  • 3.1 Global Diagnostic Nuclear Medicines Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Diagnostic Nuclear Medicines Revenue by Manufacturer (2019-2024)
  • 3.3 Global Diagnostic Nuclear Medicines Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Diagnostic Nuclear Medicines by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Diagnostic Nuclear Medicines Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Diagnostic Nuclear Medicines Manufacturer Market Share in 2023
  • 3.5 Diagnostic Nuclear Medicines Market: Overall Company Footprint Analysis
    • 3.5.1 Diagnostic Nuclear Medicines Market: Region Footprint
    • 3.5.2 Diagnostic Nuclear Medicines Market: Company Product Type Footprint
    • 3.5.3 Diagnostic Nuclear Medicines Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Diagnostic Nuclear Medicines Market Size by Region
    • 4.1.1 Global Diagnostic Nuclear Medicines Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Diagnostic Nuclear Medicines Consumption Value by Region (2019-2030)
    • 4.1.3 Global Diagnostic Nuclear Medicines Average Price by Region (2019-2030)
  • 4.2 North America Diagnostic Nuclear Medicines Consumption Value (2019-2030)
  • 4.3 Europe Diagnostic Nuclear Medicines Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Diagnostic Nuclear Medicines Consumption Value (2019-2030)
  • 4.5 South America Diagnostic Nuclear Medicines Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Diagnostic Nuclear Medicines Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Diagnostic Nuclear Medicines Sales Quantity by Type (2019-2030)
  • 5.2 Global Diagnostic Nuclear Medicines Consumption Value by Type (2019-2030)
  • 5.3 Global Diagnostic Nuclear Medicines Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Diagnostic Nuclear Medicines Sales Quantity by Application (2019-2030)
  • 6.2 Global Diagnostic Nuclear Medicines Consumption Value by Application (2019-2030)
  • 6.3 Global Diagnostic Nuclear Medicines Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Diagnostic Nuclear Medicines Sales Quantity by Type (2019-2030)
  • 7.2 North America Diagnostic Nuclear Medicines Sales Quantity by Application (2019-2030)
  • 7.3 North America Diagnostic Nuclear Medicines Market Size by Country
    • 7.3.1 North America Diagnostic Nuclear Medicines Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Diagnostic Nuclear Medicines Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Diagnostic Nuclear Medicines Sales Quantity by Type (2019-2030)
  • 8.2 Europe Diagnostic Nuclear Medicines Sales Quantity by Application (2019-2030)
  • 8.3 Europe Diagnostic Nuclear Medicines Market Size by Country
    • 8.3.1 Europe Diagnostic Nuclear Medicines Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Diagnostic Nuclear Medicines Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Diagnostic Nuclear Medicines Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Diagnostic Nuclear Medicines Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Diagnostic Nuclear Medicines Market Size by Region
    • 9.3.1 Asia-Pacific Diagnostic Nuclear Medicines Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Diagnostic Nuclear Medicines Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Diagnostic Nuclear Medicines Sales Quantity by Type (2019-2030)
  • 10.2 South America Diagnostic Nuclear Medicines Sales Quantity by Application (2019-2030)
  • 10.3 South America Diagnostic Nuclear Medicines Market Size by Country
    • 10.3.1 South America Diagnostic Nuclear Medicines Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Diagnostic Nuclear Medicines Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Diagnostic Nuclear Medicines Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Diagnostic Nuclear Medicines Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Diagnostic Nuclear Medicines Market Size by Country
    • 11.3.1 Middle East & Africa Diagnostic Nuclear Medicines Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Diagnostic Nuclear Medicines Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Diagnostic Nuclear Medicines Market Drivers
  • 12.2 Diagnostic Nuclear Medicines Market Restraints
  • 12.3 Diagnostic Nuclear Medicines Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Diagnostic Nuclear Medicines and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Diagnostic Nuclear Medicines
  • 13.3 Diagnostic Nuclear Medicines Production Process
  • 13.4 Diagnostic Nuclear Medicines Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Diagnostic Nuclear Medicines Typical Distributors
  • 14.3 Diagnostic Nuclear Medicines Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Diagnostic Nuclear Medicines. Industry analysis & Market Report on Diagnostic Nuclear Medicines is a syndicated market report, published as Global Diagnostic Nuclear Medicines Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Diagnostic Nuclear Medicines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,641.32
    		3,961.98
    		5,282.64
    		3,128.52
    		4,692.78
    		6,257.04
    		492,802.80
    		739,204.20
    		985,605.60
    		291,728.40
    		437,592.60
    		583,456.80
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo